David Friedland
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Brain Metastases and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Prostate Cancer Treatment and Research 6
- Renal cell carcinoma treatment 4
- Oncology 17
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 6
- Lung Cancer Research Studies 5
- Co-authors
- Chandra P. Belani (17 shared papers)Ramesh K. Ramanathan (13 shared papers)Suresh S. Ramalingam (11 shared papers)Ronald G. Stoller (9 shared papers)Sanjiv S. Agarwala (5 shared papers)Athanassios Argiris (5 shared papers)Robert L. Comis (3 shared papers)James D. Luketich (4 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Clinical Cancer Research (6 papers)Cancer (5 papers)Clinical Genitourinary Cancer (2 papers)Cancer Investigation (2 papers)
- Partner nations
- United StatesGreeceSouth Korea
In The Last Decade
David Friedland
59 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 94
- Oncology 349
- Pulmonary and Respiratory Medicine 398
- Genetics 95
- Biomaterials 117
- Infectious Diseases 145
Countries citing papers authored by David Friedland
This map shows the geographic impact of David Friedland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Friedland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Friedland more than expected).
Fields of papers citing papers by David Friedland
This network shows the impact of papers produced by David Friedland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Friedland. The network helps show where David Friedland may publish in the future.
Co-authors
The 25 scholars most cited alongside David Friedland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 138 | |
| 2 | A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: correlation of antitumor effect to phosphorylation of Bcl-2. | 1999 | 126 |
| 3 | 2017 | 121 | |
| 4 | 2005 | 102 | |
| 5 | 2010 | 101 | |
| 6 | 2007 | 85 | |
| 7 | 2007 | 73 | |
| 8 | 2008 | 57 | |
| 9 | 2009 | 53 | |
| 10 | 2008 | 49 | |
| 11 | 2006 | 48 | |
| 12 | 1998 | 38 | |
| 13 | 2010 | 38 | |
| 14 | 2017 | 34 | |
| 15 | 1997 | 33 | |
| 16 | 2011 | 30 | |
| 17 | 2005 | 26 | |
| 18 | 2013 | 22 | |
| 19 | 1996 | 20 | |
| 20 | 2007 | 19 |
About David Friedland
David Friedland is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Cancer Research, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Prostate Cancer Treatment and Research (6 papers), Cancer Treatment and Pharmacology (6 papers), Pneumonia and Respiratory Infections (5 papers), Lung Cancer Research Studies (5 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Oncology (349 citations), Pulmonary and Respiratory Medicine (398 citations), Genetics (95 citations), Biomaterials (117 citations) and Infectious Diseases (145 citations). David Friedland has collaborated with scholars based in United States, Greece and South Korea. Frequent co-authors include Chandra P. Belani, Ramesh K. Ramanathan, Suresh S. Ramalingam, Ronald G. Stoller, Sanjiv S. Agarwala, Athanassios Argiris, Robert L. Comis, James D. Luketich, Daniel P. Petro and Mark A. Socinski. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer, Clinical Genitourinary Cancer and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.